Nav interneta savienojuma — tiek rādīta saglabātā lapas versija.

Merck KGaA

DEEUR
← Uz akciju filtru

Merck KGaA (LSE:0O14) — Drug Manufacturers - Specialty & Generic. Biržu skaits, kurās tiek tirgotas uzņēmuma akcijas: 3. Šajā lapā — cena un grafiks, dividendes, lielākie akcionāri un akciju skaita vēsture.

⚠ Nesajauciet tos: ir vēl viens uzņēmums ar tādu pašu vai ļoti līdzīgu nosaukumu. Tas ir atsevišķs ieraksts — pārbaudiet tikeri, biržas un reģistrācijas numuru.
  • Merck KGaA ADR — 1MRKX · MI US CIK 310158 · LEI 4YV9Y5M8S0BRK1RP0397 · ISIN US58933Y1055

Par uzņēmumu

Tīmekļvietne
merckgroup.com
Nozare
Healthcare · Drug Manufacturers - Specialty & Generic
Galvenā mītne
Darmstadt, Germany
Izpilddirektors
Belén Garijo
Darbinieki
60 348
Dibināts
1668
Biržā kopš
17.07.2007 (LSE:0O14)
Apgrozībā esošās akcijas
129.24 milj.
Brīvā apgrozība
128.87 milj.
Tirgus kapitalizācija
59.93 mljrd. EUR
Iekšējās personas
0%
Institucionālie investori
57.83%
Apraksts

Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific. The Life Science segment offers products, solutions, and services to academic, research and diagnostic labs, biotech, and pharmaceutical companies, as well as the industrial sector; reagents, consumables, devices, instruments, software, and services for research, production, and testing to lab water instruments, microbiology and biomonitoring products, test assays, analytical reagents, and flow cytometry kits and instruments. This segment also provides traditional and novel therapies, such as ration devices, chromatography resins, single-use systems, process chemicals, and excipients for bioprocessing; contract development, manufacturing and testing services, which supports customers from preclinical phases to commercialization. The Healthcare segment discovers, develops, manufactures, and markets prescription drugs and biopharmaceuticals to the therapeutic areas of oncology, rare diseases, neurology and immunology, fertility, cardiovascular, and metabolic and endocrinological disorders. The Electronics segment offers advanced dielectric and metallic materials; photoresist, anti-reflective coating, and material lithography products; clean and selective etch chemistries; materials for chemical-mechanical planarization; high-purity gases for semiconductor manufacturing; and develops and installs delivery equipment for handling of specialty chemicals and gases for semiconductor manufacturing; develops modulating, creating, engineering, and guiding light; and material solutions in liquid crystals, OLED materials, and photoresists. It has in-licensing agreement with Abbisko Therapeutics Co. Ltd., China on drug candidates for the treatment of tenosynovial giant cell tumor; and strategic partnership with Versant Ventures to advance treatments for rare genetic cardiomyopathies. The company was founded in 1668 and is headquartered in Darmstadt, Germany. Merck KGaA operates as a subsidiary of E. Merck KG.

Biržas un tikeri

BiržaTikerisValūtaCenaVeids
XETRA XetraMRK galvenāEUR138.1 +0.51%parastās akcijas
LSE London Stock Exchange0O14 IOBEUR137.725 +1.64%parastās akcijas
US USA StocksMKGAF OTCUSD160.752 +4.22%parastās akcijas

Cena 3 mēnešu laikā

pieauguma diena krituma diena dividenžu ex-datums izmaksas datumsUzbrauciet / pieskarieties dienai — atvēršanas, slēgšanas, augstākā un zemākā cena

Dividendes

Pēdējie 12 mēneši, XETRA:MRK: 2.2 EUR (1 izm.)

Merck KGaA (MRK) izmaksā dividendes reizi gadā. Pēdējo 12 mēnešu laikā tika samaksāts 2.2 EUR par akciju (maksājumi: 1). Tas ir aptuveni 1.59% no pašreizējās akciju cenas. Pamatojoties uz maksājumu vēsturi, nākamais ex-dividendes datums tiek gaidīts ap 26.04.2027.

Ex-datumsIzmaksaSumma%VeidsTikeris
2026-04-272026-04-292.2000 EUR1.6/1.6 %ikgadējsXETRA:MRK
2025-04-282025-04-302.2000 EUR1.6/1.6 %ikgadējsXETRA:MRK
2024-04-29—2.2000 EUR1.6/1.6 %ikgadējsXETRA:MRK
2023-05-02—2.2000 EUR1.6/1.6 %ikgadējsXETRA:MRK
2022-04-25—1.8500 EUR1.3/1.3 %ikgadējsXETRA:MRK

Ziņas šonedēļ

Ziņu no uzņēmuma vietnes vēl nav.

reklāma

Lielākie akcionāri

TurētājsDaļaAkcijasPārskata datums
First Eagle Funds-First…4.7%6.07 milj.2026-07-31
MFS Series Trust XVII-MF…1.78%2.3 milj.2026-06-30
First Eagle Funds-First…1.59%2.06 milj.2026-07-31
VANGUARD STAR FUNDS-Vang…1.48%1.91 milj.2026-07-31
Bridge Builder Trust-Bri…1.36%1.76 milj.2026-06-30
VANGUARD TAX-MANAGED FUN…0.98%1.27 milj.2026-06-30
MFS SERIES TRUST I-MFS R…0.76%988 0282026-05-31
iShares Trust-iShares Co…0.75%964 9962026-08-31
MFS SERIES TRUST X-MFS I…0.73%947 8552026-05-31
BNY Mellon Strategic Fun…0.41%532 2002026-05-31
Generali Investments Cee…0%6 2362026-06-30
Pacer Advisors, Inc.0%4 9262026-06-30
Reik & Co., Llc0%4 0002026-06-30
Gamma Investing LLC0%342026-09-30